Several forms of eye movement dysfunction (EMD) are regarded as promising candidate endophenotypes of schizophrenia. Discrepancies in individual study results have led to inconsistent conclusions regarding particular aspects of EMD in relatives of schizophrenia patients. To quantitatively evaluate and compare the candidacy of smooth pursuit, saccade and fixation deficits in first-degree biological relatives, we conducted a set of meta-analytic investigations. Among 18 measures of EMD, memory-guided saccade accuracy and error rate, global smooth pursuit dysfunction, intrusive saccades during fixation, antisaccade error rate and smooth pursuit closed-loop gain emerged as best differentiating relatives from controls (standardized mean differences ranged from .46 to .66), with no significant differences among these measures. Anticipatory saccades, but no other smooth pursuit component measures were also increased in relatives. Visually-guided reflexive saccades were largely normal. Moderator analyses examining design characteristics revealed few variables affecting the magnitude of the meta-analytically observed effects. Moderate effect sizes of relatives v. controls in selective aspects of EMD supports their endophenotype potential. Future work should focus on facilitating endophenotype utility through attention to heterogeneity of EMD performance, relationships among forms of EMD, and application in molecular genetics studies.
Introduction
There is a growing consensus that genes influence the development of many forms of psychopathology. The hunt for implicated genes is sweeping the natural and social sciences (e.g., Plomin & McGuffin, 2003) . Arguably, this is nowhere more evident than in research on schizophrenia, a debilitating mental disorder for which a heritable component has long been recognized. But, in the ''frustrating search for schizophrenia genes" (Tsuang & Faraone, 2000) , progress has been slow. Genetic linkage studies have identified multiple susceptibility loci on many chromosomes (e.g., Badner & Gershon, 2002; Berrettini, 2000; Berry, Jobanputra, & Pal, 2003; Harrison & Owen, 2003; Jurewicz, Owen, O'Donovan, & Owen, 2001; Kato et al., 2002; Leboyer et al., 1998; Mowry & Nancarrow, 2001; Riley, 2004; Waterworth, Bassett, & Brzustowicz, 2002) and variations in particular genes have been identified in some individuals with schizophrenia. However, though evidence is accumulating that particular genes are implicated, studies have not yet consistently yielded associations between the gene aberrations and schizophrenia (for reviews see Harrison & Owen, 2003; Owen, Craddock, & O'Donovan, 2005; Riley, 2004; Waterworth et al., 2002; Wong, Buckle, & Van Tol, 2000) . The identification of genes and their mechanisms will enhance our understanding of the brain abnormalities associated with psychopathology and enable researchers to develop more targeted and effective treatments (Hyman, 2000) . As advances in molecular genetics strategies have catapulted us toward improved understanding of our basic genetic make-up, psychopathology researchers have strived to match the pace.
Unfortunately, there are several commonly recognized obstacles to the identification of disorder susceptibility genes. (Schizophrenia Research, 49, . We thank the hundreds of researchers and thousands of research participants whose efforts made this work possible, and gratefully acknowledge the effort made by the researchers whom we contacted for additional information about their work.
